Skip to content
Dosage GuideResearch Reference

Vilon Dosage

Research-based dosing protocols, timing guidance, and reconstitution reference for Vilon. All information is for educational purposes only.

Quick Answer

Vilon (Lys-Glu) has been studied primarily in preclinical settings. Research protocols involve daily doses of 10–100 mcg via subcutaneous or oral administration. No human clinical dose-ranging trials have been completed; dosages are based on animal models.

→ Vilon Benefits→ Vilon Side Effects→ Full Vilon Profile
Table of Contents

Standard Dosage Range

Research dosing range: 10–100 mcg daily (research protocols)

Educational reference only

These dosage ranges are derived from preclinical research and community protocols. No human clinical dose-ranging trials have established therapeutic doses for most research peptides. Always consult a qualified healthcare provider before starting any peptide protocol.

Dosage by Use Case

Immune System Support

10–50 mcg1× daily
Duration

4–8 weeks

Based on preclinical studies showing immune parameter restoration in aged and immunosuppressed animal models. Subcutaneous or oral administration.

Hematopoietic Stimulation

20–100 mcg1× daily
Duration

4–6 weeks

Used to enhance bone marrow colony-forming units in preclinical models. Subcutaneous administration is typical in animal research.

Support for Age-Related Immune Decline

10–50 mcg1× daily
Duration

8–12 weeks

Extended duration based on animal studies showing benefits in aged models. Oral or subcutaneous administration.

Timing & Frequency

Due to its short half-life (~20-30 minutes), timing may not be as critical. Some researchers prefer morning administration. For oral dosing, administration on an empty stomach may improve absorption.

Cycle Guidance

Preclinical studies typically run for 4–12 weeks. Given the limited human safety data, a common approach would be a 6–8 week cycle followed by a 4-week break. Vilon does not appear to suppress endogenous systems, so the cycling rationale is precautionary.

Reconstitution Reference

Quick reference for reconstituting Vilon. For custom vial sizes and concentrations, use the Reconstitution Calculator.

Common Vial SizeTypically 1 mg per vial
BAC Water Volume1 mL bacteriostatic water for 1 mg/mL concentration
Concentration & DrawAt 1 mg/mL: 10 mcg = 0.01 mL (1 unit on a 100-unit insulin syringe)
StorageRefrigerate at 2–8°C after reconstitution. Keep lyophilized powder at room temperature or refrigerated.
StabilityReconstituted solution stable up to 7 days refrigerated. Lyophilized powder stable 12-24 months per manufacturer specifications.
Use the Reconstitution Calculator → for precise injection volumes based on your exact vial size, water volume, and desired dose.

Frequently Asked Questions

What is Vilon?
Vilon (Lys-Glu) is a synthetic dipeptide bioregulator developed by Khavinson targeting immune and blood-forming tissue. It is composed of two amino acids, lysine and glutamic acid.
What are the benefits of Vilon?
Preclinical studies suggest that Vilon can stimulate bone marrow hematopoiesis and enhance immune cell production, potentially restoring immune parameters in aged or immunosuppressed individuals.
How is Vilon administered?
In research settings, Vilon is typically administered subcutaneously or orally. There are no approved human clinical guidelines for administration.
What is the dosage of Vilon?
Research protocols often use doses of 10–100 mcg daily. There are no established human clinical dosages for Vilon.
Are there any side effects of Vilon?
Preclinical studies report very few adverse effects. However, due to the limited human data, caution is advised.

Last updated: 2026-02-19